About 100 reports

  • DEVELOPMENT OF ANTIBIOTIC RESISTANCE
  • SPREAD OF ANTIBIOTIC RESISTANCE
  • Antibiotic Resistance
  • Allergan plc
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Rising government initiatives to combat antibiotic resistance
  • RISING GOVERNMENT INITIATIVES TO COMBAT ANTIBIOTIC RESISTANCE
  • Antibiotic Resistance
  • Forecast
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • May 04, 2016: Bausch + Lomb Reports Preliminary 2015 Results of the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) Study
  • May 10, 2017: Bausch + Lomb Reports Updated Results of the Antibiotic Resistance Monitoring in Ocular MicRoorganisms (ARMOR) Study
  • Antibiotic Resistance
  • Eye Disease
  • Ophthalmology
  • United States
  • Bausch & Lomb Incorporated
  • OCT 06, 2016: PENN MEDICINE RECEIVES CDC AWARD TO COMBAT ANTIBIOTIC RESISTANCE
  • JUL 27, 2016: CDC FUNDING ACCELERATES ANTIBIOTIC RESISTANCE EFFORTS
  • Antibiotic Resistance
  • Infectious Disease
  • Vaccine
  • United States
  • GlobalData's company
  • Oct 06, 2016: Synthetic Biologics Awarded Research Contract from Centers for Disease Control and Prevention (CDC) for Microbiome Assessment and Intervention to Address Antibiotic Resistance
  • Antibiotic Resistance
  • Digestive System Disorder
  • United States
  • World
  • Product Initiative
  • 12.3.4 Antibiotic Resistance Patterns
  • ILLUSTRATION DEPICTING THE KEY MECHANISMS OF ANTIBIOTIC RESISTANCE OBSERVED IN GRAM-
  • Antibiotic Resistance
  • Achaogen, Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • The Medicines Company
  • Oct 06, 2016: Synthetic Biologics Awarded Research Contract from Centers for Disease Control and Prevention (CDC) for Microbiome Assessment and Intervention to Address Antibiotic Resistance
  • Antibiotic Resistance
  • Digestive System Disorder
  • United States
  • Product Initiative
  • Synthetic Biologics
  • MOUNTING THREAT OF MICROBIAL ANTIBIOTIC RESISTANCE
  • MOUNTING THREAT OF MICROBIAL ANTIBIOTIC RESISTANCE
  • Antibiotic Resistance
  • United States
  • Alere Inc.
  • Cepheid
  • Roche Group
  • JUN 05, 2015: TAXIS PHARMACEUTICALS ANNOUNCES PUBLICATION OF DATA DEMONSTRATING POTENTIAL VIABILITY OF TXA709 IN COMBATING ANTIBIOTIC RESISTANCE
  • APR 27, 2015: TAXIS PHARMACEUTICALS DEMONSTRATES CLINICAL POTENTIAL OF TXA709 IN COMBATING ANTIBIOTIC RESISTANCE
  • Anti-Infective
  • Antibiotic Resistance
  • United States
  • World
  • Product Initiative
  • ANTIBIOTIC RESISTANCE MARKER CARTRIDGE
  • Antibiotic Resistance Marker Cartridge - Product Status
  • Antibiotic Resistance
  • China
  • Europe
  • United States
  • Curetis N.V.
  • and study to combat antibiotic resistance
  • AMR
  • Anti-Infective
  • Antibiotic Resistance
  • Pharmaceutical
  • Therapy
  • United States
  • ATLAS IO SYSTEM - BACTERIAL IDENTIFICATION AND ANTIBIOTIC RESISTANCE
  • ATLAS IO SYSTEM - BACTERIAL IDENTIFICATION AND ANTIBIOTIC RESISTANCE - PRODUCT STATUS
  • Antibiotic Resistance
  • Sexually Transmitted Disease
  • United Kingdom
  • United States
  • GlobalData's company
  • 4.6.9 CONCLUSION
  • 2.7.2 MRSA

Antibiotic resistance genes have allowed bacteria to become capable of developing resistance to antibiotics through several mechanisms.

  • Antibiotic Resistance
  • World
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • EQUITY OFFERING
  • JAN 26, 2017: OPGEN REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2016 FINANCIAL RESULTS

Announced collaboration with Merck to develop novel rapid diagnostics and informatics tools to combat antibiotic resistance.

  • Antibiotic Resistance
  • United States
  • Company
  • Demand
  • OpGen, Inc.
  • Jun 05, 2015: TAXIS Pharmaceuticals Announces Publication of Data Demonstrating Potential Viability of TXA709 in Combating Antibiotic Resistance
  • Apr 27, 2015: TAXIS Pharmaceuticals Demonstrates Clinical Potential of TXA709 in Combating Antibiotic Resistance
  • Antibiotic Resistance
  • United States
  • World
  • Product Initiative
  • Vichem
  • ANTIBIOTIC RESISTANCE
  • ANTIBIOTIC RESISTANCE PREVENTION
  • Anti-Infective
  • Antibiotic Resistance
  • United States
  • World
  • Company
  • SELECTED COMPANIES MARKETING PCR/NAAT-BASED ANTIBIOTIC RESISTANCE/SUSCEPTIBILITY TESTS
  • SELECTED COMPANIES MARKETING PCR/NAAT SYNDROMIC TESTS/PANELS FOR INFECTIOUS DISEASES
  • Antibiotic Resistance
  • Molecular Diagnostic
  • United States
  • World
  • Biocartis S.A.
  • ANTIBIOTIC RESISTANCE MARKER CARTRIDGE
  • Antibiotic Resistance Marker Cartridge - Product Status
  • Antibiotic Resistance
  • China
  • Europe
  • United States
  • Curetis N.V.
  • Apr 06, 2017: Curetis Starts Subsidiary Ares Genetics to Advance Genetic Antibiotic Resistance Testing
  • Antibiotic Resistance
  • Healthcare
  • Medical Equipment
  • United States
  • Curetis N.V.

Tetraphase Pharmaceuticals Inc (Tetraphase) is a clinical stage life science company that discovers and develops antibiotic resistance medicines.

  • Antibiotic Resistance
  • United States
  • World
  • Product Initiative
  • Soligenix, Inc.
  • KEY MILESTONES FOR EMERGENCE OF ANTIBIOTIC RESISTANCE
  • LACTAMASE MEDIATED ANTIBIOTIC RESISTANCE IN MRSA
  • Antibiotic Resistance
  • Cempra, Inc.
  • CyDex Pharmaceuticals, Inc.
  • Melinta Therapeutics, Inc.
  • Merck & Co., Inc.
  • 3.2.3 Mechanisms of Antibiotic Resistance
  • Cartoon Depicting the Key Mechanisms of Antibiotic Resistance Observed in S. aureus
  • Antibiotic Resistance
  • World
  • Allergan plc
  • Cellceutix Corporation
  • Cempra, Inc.
  • TOSATOXUMAB - DRUG PROFILE

The ERS notes that antibiotic resistance is one of the major threats undermining the treatment of respiratory infections.

  • Antibiotic Resistance
  • United States
  • World
  • Product Initiative
  • Cempra, Inc.

This approach is less susceptible to development of antibiotic resistance, can be used both therapeutically and prophylactically.

  • Antibiotic Resistance
  • Infectious Disease
  • United States
  • World
  • Product Initiative
  • Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Product Development Milestones

" The figures highlighted in Jim O' Neill' s report - and in particular the potential human cost of not addressing antibiotic resistance - are significant.

  • Antibiotic Resistance
  • United Kingdom
  • World
  • Product Initiative
  • MGB Biopharma Limited
  • Feb 23, 2017: Accelerate Diagnostics Receives FDA Marketing Authorization for the Accelerate Pheno System

The faster we can tailor therapy, the better things are for the patient and the potential prevention of antibiotic resistance. "

  • Antibiotic Resistance
  • United States
  • Company
  • Product Initiative
  • Accelerate Diagnostics, Inc.
  • JUL 13, 2016: UNMC RESEARCHER SECURES $2.25 MILLION GRANT TO FIGHT ANTIBIOTIC RESISTANCE
  • R&D Progress
  • Anti-Infective
  • Antibiotic Resistance
  • Healthcare
  • United States
  • Product Initiative
  • R&D Progress
  • SMALL MOLECULE TO INHIBIT DNA-DIRECTED RNA POLYMERASE SUBUNIT BETA AND HIV INTEGRASE FOR HIV AND TUBERCULOSIS - DRUG PROFILE
  • Antibiotic Resistance
  • DNA
  • United States
  • World
  • Product Initiative
  • 3.2.3 Mechanisms of Antibiotic Resistance
  • illustrates the primary mechanisms of antibiotic resistance known to be utilized by S.
  • Antibiotic Resistance
  • Cempra, Inc.
  • Debiopharm Group
  • Melinta Therapeutics, Inc.
  • Merck & Co., Inc.
  • 3.2.3 Mechanisms of Antibiotic Resistance
  • Cartoon Depicting the Key Mechanisms of Antibiotic Resistance Observed in S. aureus
  • Antibiotic Resistance
  • Cempra, Inc.
  • Debiopharm Group
  • Melinta Therapeutics, Inc.
  • Merck & Co., Inc.